Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Payables (2023 - 2025)

Baird Medical Investment Holdings' quarterly Payables came in at $12.2 million in Q4 2025, down 29.75% year-on-year from $17.4 million in Q4 2024, and down 12.3% quarter-over-quarter from $14.0 million in Q2 2025.

Baird Medical Investment Holdings has reported Payables for 3 years, with the latest figure at $12.2 million in Q4 2025.

  • For the quarter ending Q4 2025, Payables fell 29.75% year-over-year to $12.2 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (down 29.75% YoY), and the FY2025 full-year result was $12.2 million, down 29.75% from the prior year.
  • Payables for Q4 2025 stood at $12.2 million, down from $14.0 million in the prior quarter.
  • The five-year high for Payables was $17.4 million in Q4 2024, with the low at $8.7 million in Q4 2023.
  • Average Payables over 3 years is $13.1 million, with a median of $13.1 million recorded in 2025.
  • Year-over-year, Payables soared 99.83% in 2024 and dropped 29.75% in 2025.
  • Tracing BDMDW's Payables over 3 years: stood at $8.7 million in 2023, then jumped by 99.83% to $17.4 million in 2024, then declined by 29.75% to $12.2 million in 2025.
  • The last three Payables figures came in at $12.2 million (Q4 2025), $14.0 million (Q2 2025), and $17.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.78 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 1.93 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 2.57 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.14 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 181.10 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.74 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.07 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 3.42 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 457.70 Mn
10 Baird Medical Investment Holdings - - - 12.24 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 12.24 Mn
Jun 30, 2025 13.95 Mn
Dec 31, 2024 17.42 Mn
Dec 31, 2023 8.72 Mn